TrialThe Journal of biological chemistry2012

Nifetepimine, a dihydropyrimidone, ensures CD4+ T cell survival in a tumor microenvironment by maneuvering sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA).

Swatilekha Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.